Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Palatin Technologies, Inc. (PTN)
USD9.05
+0.20 (+2.26%)
US NASDAQ Healthcare Biotechnology
Address
11 Deer Park Drive 8512
Monmouth Junction, NJ, US
Monmouth Junction, NJ, US
CEO
Carl Spana
Website
palatin.com
IPO
1997-10-15
ISIN US6960776010
Also trades on
London Stock Exchange · 0KF3.L (USD)
New York Stock Exchange American · PTN (USD)
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and Bremelanotide co-administration with Tirzepatide to treat obesity in Phase 2 trial, as well as Bremelanotide co-formulated with a PDE5i for the treatment of ED in patients not adequately responsive to PDE5i monotherapy. The company also develops PL9643 for dry eye disease and anti-inflammatory ocular indications; and oral PL8177 for the treatment inflammatory bowel diseases. Palatin Technologies, Inc. was incorporated in 1986 and is based in Monmouth Junction, New Jersey.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD9.05
+0.20 (+2.26%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
14.2K
Beta
-0.11
Float Shares
23.53M
Free Float %
90.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -16.01% | -9.27% | -10.59% | -4.83% | +53.24% | +7.61% | +267.78% | -87.22% | -97.24% | -97.50% | -99.97% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
9.05
Low
50.00
+452.5%
Consensus
55.00
+507.7%
Median
55.00
+507.7%
High
60.00
+563.0%
DCF (Levered)
4.46
-50.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2025-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 2 |
55.00
+507.7%
|
| All Time | 2 |
55.00
+507.7%
|
Quality scores
Altman Z-Score
49.03
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
5 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-100.0%
-
EPS growth Biotechnology: +29.7%-1,491.6% Q1'26: +41.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +0.0% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%-96.3% ★ Q1'26: -48.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.01× Q1'26: -0.05× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Jun 2015 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 1 Rev. Ana. 1 EPS Ana. |
Jun 2027 1 Rev. Ana. 1 EPS Ana. |
Jun 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
12.95M
est: 13.48M (-3.9%)
|
44.72M
est: 20.10M (+122.6%)
|
67.13M
est: 55.37M (+21.2%)
|
60.30M
est: 11.7K (+516,746.5%)
|
118.0K
est: 112.0K (+5.3%)
|
-188.6K
est: 187.7K (-200.5%)
|
1.47M
est: 900.0K (+63.2%)
|
4.85M
est: 4.32M (+12.2%)
|
4.49M
est: 4.12M (+9.0%)
|
—
est: 5.25M (-100.0%)
|
74.49M
74.49M – 74.49M
+1,318.8% YoY
|
152.36M
152.36M – 152.36M
+104.6% YoY
|
111.30M
111.30M – 111.30M
-27.0% YoY
|
| EBITDA |
-17.42M
est: -2.70M (-546.3%)
|
-10.51M
est: -4.02M (-161.5%)
|
25.98M
est: -11.07M (+334.6%)
|
35.80M
est: -2.3K (+1,534,731.6%)
|
-22.34M
est: -22.4K (-99,644.1%)
|
-33.52M
est: -37.5K (-89,213.2%)
|
-35.68M
est: -180.0K (-19,723.8%)
|
-28.40M
est: -864.9K (-3,183.9%)
|
-29.38M
est: -824.0K (-3,465.5%)
|
-17.03M
est: -1.05M (-1,522.2%)
|
-14.90M
-14.90M – -14.90M
-1,318.8% YoY
|
-30.47M
-30.47M – -30.47M
-104.6% YoY
|
-22.26M
-22.26M – -22.26M
+27.0% YoY
|
| EBIT |
-17.54M
est: -2.70M (-550.6%)
|
-10.54M
est: -4.02M (-162.3%)
|
25.93M
est: -11.07M (+334.1%)
|
35.74M
est: -2.3K (+1,532,218.3%)
|
-22.41M
est: -22.4K (-99,930.7%)
|
-33.60M
est: -37.5K (-89,411.9%)
|
-36.17M
est: -180.0K (-19,993.8%)
|
-28.69M
est: -864.9K (-3,217.2%)
|
-29.72M
est: -824.0K (-3,506.7%)
|
-17.29M
est: -1.05M (-1,546.9%)
|
-14.90M
-14.90M – -14.90M
-1,318.8% YoY
|
-30.47M
-30.47M – -30.47M
-104.6% YoY
|
-22.26M
-22.26M – -22.26M
+27.0% YoY
|
| Net Income |
-17.67M
est: -1.45M (-1,121.0%)
|
-13.33M
est: -1.82M (-633.7%)
|
24.70M
est: 1.08M (+2,194.3%)
|
35.77M
est: -1.29M (+2,868.3%)
|
-22.43M
est: -1.15M (-1,844.6%)
|
-33.57M
est: -1.46M (-2,205.2%)
|
-36.20M
est: -1.70M (-2,025.6%)
|
-24.04M
est: -1.02M (-2,249.9%)
|
-29.74M
est: -1.35M (-2,098.8%)
|
-17.31M
est: -533.0K (-3,147.4%)
|
1.01M
1.01M – 1.01M
+289.9% YoY
|
3.04M
3.04M – 3.04M
+200.0% YoY
|
279.9K
279.9K – 279.9K
-90.8% YoY
|
| SGA |
5.68M
est: -198.90M (+102.9%)
|
9.61M
est: -296.61M (+103.2%)
|
8.64M
est: -817.27M (+101.1%)
|
9.70M
est: -172.2K (+5,732.4%)
|
9.77M
est: -1.65M (+690.7%)
|
17.34M
est: -2.77M (+725.9%)
|
16.51M
est: -13.28M (+224.3%)
|
15.29M
est: -63.83M (+124.0%)
|
12.27M
est: -60.81M (+120.2%)
|
7.55M
est: -77.49M (+109.7%)
|
-1.10B
-1.10B – -1.10B
-1,318.8% YoY
|
-2.25B
-2.25B – -2.25B
-104.6% YoY
|
-1.64B
-1.64B – -1.64B
+27.0% YoY
|
| EPS |
-3.65
est: -2.69 (-35.8%)
|
-1.81
est: -3.38 (+46.4%)
|
3.12
est: 2.00 (+56.0%)
|
4.31
est: -2.40 (+279.6%)
|
-2.38
est: -2.14 (-11.1%)
|
-3.55
est: -2.71 (-31.2%)
|
-3.79
est: -3.16 (-19.8%)
|
-2.21
est: -1.90 (-16.3%)
|
-2.02
est: -2.51 (+19.6%)
|
-32.15
est: -0.99 (-3,147.5%)
|
1.88
1.88 – 1.88
+289.9% YoY
|
5.64
5.64 – 5.64
+200.0% YoY
|
0.52
0.52 – 0.52
-90.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-13 | C+ | 2/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-12 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-11 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-08 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-07 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-06 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-05 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-04 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-05-01 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-30 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-29 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-28 | B- | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 | 1/5 | 4/5 |
| 2026-04-27 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-24 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-23 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-22 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-21 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-20 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-17 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
| 2026-04-16 | B- | 2/5 | 5/5 | 1/5 | 1/5 | 2/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-16.77M
OE per share TTM
-8.96
Owner's Yield
-25.90%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
9.9%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
22
Total invested
13.00M
Insider transactions (90d)
0
Beneficial owners (>5%)
29
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BAM Management, LLC | 9.48M | 9.86% | — | 9.48M | — | — | OO | Delaware, U.S.A. | 2009-08-17 | ↗ |
| 2 | BAM Opportunity Fund, L.P. | 9.48M | 9.86% | — | 9.48M | — | — | PN | Delaware, U.S.A. | 2009-08-17 | ↗ |
| 3 | Ross Berman | 9.48M | 9.86% | — | 9.48M | — | — | IN | United States of America | 2009-08-17 | ↗ |
| 4 | LLC | 5.10M | 2.54% | — | 5.10M | — | 5.10M | OO | Delaware | 2018-02-14 | ↗ |
| 5 | QVT Financial LP | 5.10M | 2.54% | — | 5.10M | — | 5.10M | PN | Delaware | 2018-02-14 | ↗ |
| 6 | Deerfield Special Situations Fund International Limited | 3.93M | 9.99% | — | 3.93M | — | — | CO | Delaware | 2011-03-07 | ↗ |
| 7 | 01-0798253 | 3.89M | 9.99% | — | 3.89M | — | — | OO | Delaware | 2012-07-10 | ↗ |
| 8 | 11-3694007 | 3.89M | 9.99% | — | 3.89M | — | — | OO | Delaware | 2012-07-10 | ↗ |
| 9 | LP | 3.79M | 1.90% | — | 3.79M | — | 3.79M | PN | Islands | 2018-02-14 | ↗ |
| 10 | (1) BlackRock, Inc. | 3.74M | 1.60% | 3.74M | — | 3.74M | — | HC | Delaware | 2020-07-10 | ↗ |
| 11 | QUOGUE CAPITAL LLC | 3.65M | 11.00% | — | 3.65M | — | 3.65M | OO | New York | 2011-02-28 | ↗ |
| 12 | WAYNE P. ROTHBAUM | 3.65M | 11.00% | — | 3.65M | — | 3.65M | IN | United States | 2011-02-28 | ↗ |
| 13 | BVF Inc. | 3.40M | 4.80% | — | 3.40M | — | — | CO | Delaware | 2016-02-16 | ↗ |
| 14 | BVF Partners L.P. | 3.40M | 4.80% | — | 3.40M | — | — | IA, PN | Delaware | 2016-02-16 | ↗ |
| 15 | Mark N. Lampert | 3.40M | 4.80% | — | 3.40M | — | — | IN | United States | 2016-02-16 | ↗ |
| 16 | Deerfield Management Company, L.P. | 2.97M | 2.18% | — | 2.97M | — | — | PN | Delaware | 2017-02-14 | ↗ |
| 17 | Deerfield Mgmt, L.P. | 2.97M | 2.18% | — | 2.97M | — | — | PN | Delaware | 2017-02-14 | ↗ |
| 18 | Deerfield Special Situations Fund, L.P. | 2.97M | 2.18% | — | 2.97M | — | — | PN | Delaware | 2017-02-14 | ↗ |
| 19 | James E. Flynn | 2.97M | 2.18% | — | 2.97M | — | — | IN | Delaware | 2017-02-14 | ↗ |
| 20 | 98-1034191 | 2.96M | 7.59% | — | 2.96M | — | — | PN | Delaware | 2012-07-10 | ↗ |
| 21 | Deerfield Capital, L.P. | 2.57M | 7.12% | — | 2.57M | — | — | PN | Delaware | 2011-03-07 | ↗ |
| 22 | Tax ID # 57-1156902 | 1.80M | 5.12% | — | — | — | — | IA | State of Delaware | 2012-01-13 | ↗ |
| 23 | BVF Investments, L.L.C. | 1.57M | 2.30% | — | 1.57M | — | — | OO | Delaware | 2016-02-16 | ↗ |
| 24 | Armistice Capital, LLC | 1.06M | 9.99% | — | 1.06M | — | — | IA, OO | Delaware | 2023-02-14 | ↗ |
| 25 | Steven Boyd | 1.06M | 9.99% | — | 1.06M | — | — | HC, IN | United States of America | 2023-02-14 | ↗ |
| 26 | Biotechnology Value Fund, L.P. | 784.0K | 1.10% | — | 784.0K | — | — | PN | Delaware | 2016-02-16 | ↗ |
| 27 | Biotechnology Value Fund II, L.P. | 542.0K | 1.00% | — | 542.0K | — | — | PN | Delaware | 2016-02-16 | ↗ |
| 28 | MSI BVF SPV, LLC | 312.5K | 1.00% | — | 312.5K | — | — | IA, PN | Delaware | 2016-02-16 | ↗ |
| 29 | Investment 10, L.L.C. | 195.0K | 1.00% | — | 195.0K | — | — | OO | Illinois | 2016-02-16 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2025 Q4
Investors holding
22
+22 vs prev Q
New positions
22
Closed positions
0
Increased
22
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 19.0K +19.0K (+100.0%) | 330.6K +330.6K (+100.0%) | 1.95% +1.953 pp | 0.00% +0.000 pp | USD17.42 +0.0% | 1 qtrs NEW |
| 2 | MILLER FINANCIAL SERVICES LLC | 12.6K +12.6K (+100.0%) | 219.5K +219.5K (+100.0%) | 1.30% +1.297 pp | 0.24% +0.240 pp | USD17.42 +0.0% | 1 qtrs NEW |
| 3 | LPL FINANCIAL LLC | 12.6K +12.6K (+100.0%) | 218.7K +218.7K (+100.0%) | 1.29% +1.292 pp | 0.00% +0.000 pp | USD17.42 +0.0% | 1 qtrs NEW |
| 4 | VANGUARD FIDUCIARY TRUST CO | 8.8K +8.8K (+100.0%) | 152.8K +152.8K (+100.0%) | 0.90% +0.903 pp | 0.00% +0.000 pp | USD17.42 +0.0% | 1 qtrs NEW |
| 5 | UBS GROUP AG | 3.3K +2.5K (+298.2%) | 58.0K +45.1K (+351.0%) | 0.34% +0.257 pp | 0.00% +0.000 pp | USD16.91 +3.0% | 2 qtrs — |
| 6 | VANGUARD GLOBAL ADVISERS, LLC | 1.3K +1.3K (+100.0%) | 21.8K +21.8K (+100.0%) | 0.13% +0.129 pp | 0.00% +0.000 pp | USD17.42 +0.0% | 1 qtrs NEW |
| 7 | SBI SECURITIES CO., LTD. | 13.00 +8.0 (+160.0%) | 226.00 +149.0 (+193.5%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD16.54 +5.3% | 2 qtrs — |
| 8 | WELLS FARGO & COMPANY/MN | 8.00 +— (+0.0%) | 139.00 +16.0 (+13.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD15.38 +13.3% | 2 qtrs — |
| 9 | BLACKROCK, INC. | — -119.0 (-100.0%) | — -1.8K (-100.0%) | 0.00% -0.012 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 10 | JANE STREET GROUP, LLC | — -10.8K (-100.0%) | — -165.7K (-100.0%) | 0.00% -1.109 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 2 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.00% | 53.1K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 259.1K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
2.75
Bullish
Ratio by volume
3.00
Bullish
Buys
22
Sells
8
Shares acquired
19.1K
Shares disposed
574.00
Cash buys
—
Cash sales
—
Net activity
+18,562
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-30 | WILLS STEPHEN T | Officer | F-InKind | D | Common Stock | 26 | 21.38 | 555.88 | 63,462 | D | ↗ |
| 2025-12-30 | SPANA CARL | Director / Officer | F-InKind | D | Common Stock | 40 | 21.38 | 855.20 | 64,658 | D | ↗ |
| 2025-12-24 | WILLS STEPHEN T | Officer | S-Sale | D | Common Stock | 565 | 16.74 | 9.5K | 63,488 | D | ↗ |
| 2025-12-09 | WILLS STEPHEN T | Officer | A-Award | A | Common Stock | 95 | 0.00 | — | 63,378 | D | ↗ |
| 2025-12-09 | SPANA CARL | Director / Officer | A-Award | A | Common Stock | 380 | 0.00 | — | 64,303 | D | ↗ |
| 2025-12-09 | PRENDERGAST JOHN K A | Director | A-Award | A | Stock Option (Right to Buy) | 1,600 | 21.38 | 34.2K | 25,681 | D | ↗ |
| 2025-12-09 | Morris Arlene | Director | A-Award | A | Stock Option (Right to Buy) | 2,400 | 21.38 | 51.3K | 3,527 | D | ↗ |
| 2025-12-09 | DUNTON ALAN W | Director | A-Award | A | Stock Option (Right to Buy) | 1,200 | 21.38 | 25.7K | 25,999 | D | ↗ |
| 2025-11-14 | WILLS STEPHEN T | Officer | F-InKind | D | Common Stock | 95 | 5.50 | 522.50 | 32,583 | D | ↗ |
| 2025-11-14 | SPANA CARL | Director / Officer | F-InKind | D | Common Stock | 142 | 5.50 | 781.00 | 33,113 | D | ↗ |
| 2025-06-13 | WILLS STEPHEN T | Officer | P-Purchase | A | Series I warrants | 2,727,272 | 0.11 | 300.0K | 3,017,838 | D | ↗ |
| 2025-06-13 | SPANA CARL | Director / Officer | P-Purchase | A | Series I warrants | 2,727,272 | 0.11 | 300.0K | 3,060,655 | D | ↗ |
| 2025-06-13 | DUNTON ALAN W | Director | P-Purchase | A | Series D Preferred Stock | 200 | 20,000.00 | 4.00M | 224,112 | D | ↗ |
| 2025-05-07 | DEVEER ROBERT K JR | Director | P-Purchase | A | Common Stock | 100,000 | 0.10 | 10.2K | 138,065 | D | ↗ |
| 2024-08-01 | WILLS STEPHEN T | Officer | S-Sale | D | Common Stock | 2,499 | 1.66 | 4.1K | 237,956 | — | ↗ |
| 2024-07-30 | WILLS STEPHEN T | Officer | F-InKind | D | Common Stock | 3,350 | 1.88 | 6.3K | 240,455 | — | ↗ |
| 2024-07-30 | SPANA CARL | Director / Officer | F-InKind | D | Common Stock | 5,056 | 1.88 | 9.5K | 261,459 | — | ↗ |
| 2024-07-15 | WILLS STEPHEN T | Officer | A-Award | A | Stock Option (Right to Buy) | 99,000 | 1.83 | 181.2K | 276,416 | — | ↗ |
| 2024-07-15 | SPANA CARL | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 113,500 | 1.83 | 207.7K | 316,537 | — | ↗ |
| 2024-07-15 | PRENDERGAST JOHN K A | Director | A-Award | A | Common Stock | 16,000 | 0.00 | — | 63,310 | — | ↗ |
| 2024-07-15 | Morris Arlene | Director | A-Award | A | Common Stock | 12,000 | 0.00 | — | 41,580 | — | ↗ |
| 2024-07-15 | Manning Anthony M. | Director | A-Award | A | Common Stock | 12,000 | 0.00 | — | 36,080 | — | ↗ |
| 2024-07-15 | Hull Joseph Stanley | Director | A-Award | A | Common Stock | 12,000 | 0.00 | — | 42,272 | — | ↗ |
| 2024-07-15 | DUNTON ALAN W | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 183.00 | 3.11M | 57,780 | — | ↗ |
| 2024-07-15 | DEVEER ROBERT K JR | Director | A-Award | A | Common Stock | 12,000 | 0.00 | — | 38,065 | — | ↗ |
| 2024-06-04 | WILLS STEPHEN T | Officer | A-Award | A | Common Stock | 12,218 | 0.00 | — | 325,626 | — | ↗ |
| 2024-06-04 | SPANA CARL | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 13,565 | 14.50 | 196.7K | 330,102 | — | ↗ |
| 2024-05-06 | SPANA CARL | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 21,993 | 2.19 | 48.2K | 374,364 | — | ↗ |
| 2024-04-11 | DEVEER ROBERT K JR | Director | P-Purchase | A | Common Stock | 6,000 | 2.12 | 12.7K | 40,845 | — | ↗ |
| 2024-03-06 | DEVEER ROBERT K JR | Director | S-Sale | D | Common Stock | 200 | 2.00 | 400.00 | 37,574 | — | ↗ |
| 2023-12-06 | WILLS STEPHEN T | Officer | S-Sale | D | Common Stock | 2,807 | 2.42 | 6.8K | 329,713 | — | ↗ |
| 2023-12-04 | DUNTON ALAN W | Director | S-Sale | D | Common Stock | 199 | 2.48 | 493.52 | 45,075 | — | ↗ |
| 2023-08-15 | WILLS STEPHEN T | Officer | F-InKind | D | Common Stock | 455 | 2.17 | 987.35 | 332,520 | — | ↗ |
| 2023-08-15 | SPANA CARL | Director / Officer | F-InKind | D | Common Stock | 851 | 2.17 | 1.8K | 367,001 | — | ↗ |
| 2023-07-15 | Morris Arlene | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 1.83 | 31.1K | 57,180 | — | ↗ |
| 2023-07-15 | Manning Anthony M. | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 1.83 | 31.1K | 54,280 | — | ↗ |
| 2023-07-15 | Hull Joseph Stanley | Director | A-Award | A | Stock Option (Right to Buy) | 17,000 | 1.83 | 31.1K | 57,780 | — | ↗ |
| 2023-06-20 | WILLS STEPHEN T | Officer | A-Award | A | Common Stock | 4,543 | 0.00 | — | 334,943 | — | ↗ |
| 2023-06-20 | SPANA CARL | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 8,984 | 13.75 | 123.5K | 0 | — | ↗ |
| 2023-06-20 | PRENDERGAST JOHN K A | Director | A-Award | A | Common Stock | 13,000 | 0.00 | — | 76,823 | — | ↗ |
| 2023-06-20 | Morris Arlene | Director | A-Award | A | Common Stock | 10,000 | 0.00 | — | 45,093 | — | ↗ |
| 2023-06-20 | Manning Anthony M. | Director | A-Award | A | Common Stock | 10,000 | 0.00 | — | 36,693 | — | ↗ |
| 2023-06-20 | Hull Joseph Stanley | Director | A-Award | A | Common Stock | 10,000 | 0.00 | — | 47,585 | — | ↗ |
| 2023-06-20 | DUNTON ALAN W | Director | A-Award | A | Common Stock | 10,000 | 0.00 | — | 47,807 | — | ↗ |
| 2023-06-20 | DEVEER ROBERT K JR | Director | A-Award | A | Common Stock | 10,000 | 0.00 | — | 49,078 | — | ↗ |
| 2022-12-27 | WILLS STEPHEN T | Director | P-Purchase | A | Common Stock | 2,640 | 2.20 | 5.8K | 259,741 | — | ↗ |
| 2022-12-27 | SPANA CARL | Director | P-Purchase | A | Common Stock | 5,000 | 2.23 | 11.2K | 288,604 | — | ↗ |
| 2022-12-21 | DUNTON ALAN W | Director | S-Sale | D | Common Stock | 200 | 2.97 | 594.00 | 41,420 | — | ↗ |
| 2022-12-15 | WILLS STEPHEN T | Director | J-Other | D | Stock Option granted 6/27/2013 | 10,000 | 0.00 | — | 371,321 | — | ↗ |
| 2022-12-15 | SPANA CARL | Director | J-Other | D | Stock Option granted 6/11/2015 | 12,000 | 0.00 | — | 396,964 | — | ↗ |
| 2022-10-25 | WILLS STEPHEN T | Director | F-InKind | D | Common Stock | 1,527 | 7.00 | 10.7K | 379,924 | — | ↗ |
| 2022-10-25 | SPANA CARL | Director | F-InKind | D | Common Stock | 853 | 7.75 | 6.6K | 420,326 | — | ↗ |
| 2022-06-24 | WILLS STEPHEN T | Director | A-Award | A | Stock Option (Right to Buy) | 186,375 | 0.00 | — | 186,375 | — | ↗ |
| 2022-06-24 | SPANA CARL | Director / Officer | A-Award | A | Common Stock | 43,528 | 0.00 | — | 10,526,458 | — | ↗ |
| 2022-06-23 | Hull Joseph Stanley | Director | A-Award | A | Stock Option (Right to Buy) | 128,000 | 0.00 | — | 128,000 | — | ↗ |
| 2022-06-22 | WILLS STEPHEN T | Officer | A-Award | A | Stock Option (Right to Buy) | 211,136 | 0.58 | 122.5K | 211,136 | — | ↗ |
| 2022-06-22 | SPANA CARL | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 677,000 | 0.29 | 196.3K | 677,000 | — | ↗ |
| 2022-06-22 | PRENDERGAST JOHN K A | Director | A-Award | A | Stock Option (Right to Buy) | 173,000 | 0.00 | — | 173,000 | — | ↗ |
| 2022-06-22 | Morris Arlene | Director | A-Award | A | Stock Option (Right to Buy) | 128,000 | 0.00 | — | 128,000 | — | ↗ |
| 2022-06-22 | Manning Anthony M. | Director | A-Award | A | Stock Option (Right to Buy) | 128,000 | 0.00 | — | 128,000 | — | ↗ |
| 2022-06-22 | Hull Joseph Stanley | Director | A-Award | A | Common Stock | 73,000 | 0.00 | — | 980,967 | — | ↗ |
| 2022-06-22 | DUNTON ALAN W | Director | A-Award | A | Stock Option (Right to Buy) | 128,000 | 0.29 | 37.1K | 128,000 | — | ↗ |
| 2022-06-22 | DEVEER ROBERT K JR | Director | A-Award | A | Common Stock | 73,000 | 0.00 | — | 1,018,307 | — | ↗ |
| 2021-08-13 | WILLS STEPHEN T | Officer | F-InKind | D | Common stock | 13,847 | 0.56 | 7.8K | 7,652,885 | — | ↗ |
| 2021-08-13 | SPANA CARL | Director / Officer | F-InKind | D | Common Stock | 61,628 | 0.56 | 34.5K | 8,643,424 | — | ↗ |
| 2021-07-01 | Morris Arlene | Director | P-Purchase | A | Common stock | 33,000 | 0.62 | 20.5K | 698,666 | — | ↗ |
| 2021-07-01 | Hull Joseph Stanley | Director | P-Purchase | A | Common stock | 10,000 | 0.61 | 6.1K | 775,966 | — | ↗ |
| 2021-06-30 | WILLS STEPHEN T | Officer | A-Award | A | Common Stock | 1,243 | 0.60 | 745.80 | 7,660,939 | — | ↗ |
| 2021-06-30 | SPANA CARL | Director / Officer | A-Award | A | Common Stock | 64,400 | 0.62 | 39.9K | 8,694,451 | — | ↗ |
| 2021-06-30 | DUNTON ALAN W | Director | A-Award | A | Common Stock | 10,000 | 0.62 | 6.2K | 776,518 | — | ↗ |
| 2021-06-22 | WILLS STEPHEN T | Officer | A-Award | A | Stock option (right to buy) | 179,985 | 0.58 | 104.4K | 179,985 | — | ↗ |
| 2021-06-22 | SPANA CARL | Director / Officer | A-Award | A | Stock option (right to buy) | 208,943 | 0.58 | 121.2K | 208,985 | — | ↗ |
| 2021-06-22 | PRENDERGAST JOHN K A | Director | A-Award | A | Common stock | 105,000 | 0.00 | — | 1,361,683 | — | ↗ |
| 2021-06-22 | Morris Arlene | Director | A-Award | A | Common stock | 77,000 | 0.00 | — | 665,666 | — | ↗ |
| 2021-06-22 | Manning Anthony M. | Director | A-Award | A | Common Stock | 77,000 | 0.00 | — | 461,666 | — | ↗ |
| 2021-06-22 | Hull Joseph Stanley | Director | A-Award | A | Stock Option (Right to Buy) | 128,000 | 0.55 | 70.4K | 128,000 | — | ↗ |
| 2021-06-22 | DUNTON ALAN W | Director | A-Award | A | Stock Option (Right to Buy) | 128,000 | 0.55 | 70.4K | 128,000 | — | ↗ |
| 2021-06-22 | DEVEER ROBERT K JR | Director | A-Award | A | Common stock | 77,000 | 0.00 | — | 813,306 | — | ↗ |
| 2020-11-18 | DEVEER ROBERT K JR | Director | P-Purchase | A | Common Stock | 54,000 | 0.41 | 22.1K | 728,638 | — | ↗ |
| 2020-09-29 | DEVEER ROBERT K JR | Director | S-Sale | D | Common stock | 54,000 | 0.46 | 25.0K | 643,472 | — | ↗ |
| 2020-08-31 | WILLS STEPHEN T | Officer | F-InKind | D | Common Stock | 11,770 | 0.55 | 6.5K | 6,393,894 | — | ↗ |
| 2020-08-31 | SPANA CARL | Director / Officer | F-InKind | D | Common Stock | 20,208 | 0.55 | 11.1K | 7,187,368 | — | ↗ |
| 2020-06-25 | WILLS STEPHEN T | Officer | A-Award | A | Stock Option (Right to Buy) | 461,500 | 0.58 | 267.7K | 461,500 | — | ↗ |
| 2020-06-25 | SPANA CARL | Director / Officer | A-Award | A | Common Stock | 323,250 | 0.00 | — | 7,097,102 | — | ↗ |
| 2020-06-24 | WILLS STEPHEN T | Officer | A-Award | A | Common Stock | 42,925 | 0.00 | — | 6,334,414 | — | ↗ |
| 2020-06-24 | SPANA CARL | Director / Officer | A-Award | A | Common Stock | 50,150 | 0.00 | — | 7,147,252 | — | ↗ |
| 2020-06-22 | Manning Anthony M. | Director | A-Award | A | Stock Option (Right to Buy) | 128,000 | 0.55 | 70.4K | 128,000 | — | ↗ |
| 2020-06-16 | WILLS STEPHEN T | Officer | A-Award | A | Common Stock | 278,500 | 0.00 | — | 6,291,489 | — | ↗ |
| 2020-06-16 | SPANA CARL | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 535,750 | 0.58 | 310.7K | 535,750 | — | ↗ |
| 2020-06-16 | Rossetti Angela | Director | A-Award | A | Stock Option (Right to Buy) | 127,000 | 0.58 | 73.7K | 127,000 | — | ↗ |
| 2020-06-16 | PRENDERGAST JOHN K A | Director | A-Award | A | Stock Option (right to buy) | 172,000 | 0.58 | 99.8K | 172,000 | — | ↗ |
| 2020-06-16 | Morris Arlene | Director | A-Award | A | Stock Option (Right to Buy) | 127,000 | 0.58 | 73.7K | 127,000 | — | ↗ |
| 2020-06-16 | Manning Anthony M. | Director | A-Award | A | Stock Option (right to buy) | 127,000 | 0.58 | 73.7K | 127,000 | — | ↗ |
| 2020-06-16 | Hull Joseph Stanley | Director | A-Award | A | Stock Option (Right to Buy) | 127,000 | 0.58 | 73.7K | 127,000 | — | ↗ |
| 2020-06-16 | DUNTON ALAN W | Director | A-Award | A | Common Stock | 73,000 | 0.00 | — | 578,935 | — | ↗ |
| 2020-06-16 | DEVEER ROBERT K JR | Director | A-Award | A | Common Stock | 73,000 | 0.00 | — | 669,723 | — | ↗ |
| 2019-08-05 | Hull Joseph Stanley | Director | P-Purchase | A | Common Stock | 800 | 0.78 | 627.44 | 520,799 | — | ↗ |
| 2019-08-02 | SPANA CARL | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.86 | 17.3K | 5,993,852 | — | ↗ |
| 2019-08-01 | WILLS STEPHEN T | Officer | P-Purchase | A | Common Stock | 50,000 | 0.87 | 43.3K | 5,314,239 | — | ↗ |
| 2019-08-01 | SPANA CARL | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.86 | 17.3K | 5,973,852 | — | ↗ |
| 2019-08-01 | DEVEER ROBERT K JR | Director | P-Purchase | A | Common Stock | 22,580 | 0.86 | 19.4K | 568,139 | — | ↗ |
| 2019-06-24 | WILLS STEPHEN T | Officer | A-Award | A | Stock Option (right to buy) | 237,500 | 0.85 | 201.9K | 237,500 | — | ↗ |
| 2019-06-24 | SPANA CARL | Director / Officer | A-Award | A | Stock Option (right to buy) | 744,000 | 1.34 | 997.0K | 744,000 | — | ↗ |
| 2019-06-24 | Rossetti Angela | Director | A-Award | A | Common Stock | 32,000 | 0.00 | — | 393,333 | — | ↗ |
| 2019-06-24 | PRENDERGAST JOHN K A | Director | A-Award | A | Stock Option (right to buy) | 70,000 | 1.34 | 93.8K | 70,000 | — | ↗ |
| 2019-06-24 | Morris Arlene | Director | A-Award | A | Common Stock | 32,000 | 0.00 | — | 335,333 | — | ↗ |
| 2019-06-24 | Manning Anthony M. | Director | A-Award | A | Stock Option (right to buy) | 52,000 | 1.34 | 69.7K | 52,000 | — | ↗ |
| 2019-06-24 | Hull Joseph Stanley | Director | A-Award | A | Stock Option (right to buy) | 52,000 | 1.34 | 69.7K | 52,000 | — | ↗ |
| 2019-06-24 | DUNTON ALAN W | Director | A-Award | A | Stock Option (right to buy) | 52,000 | 1.34 | 69.7K | 52,000 | — | ↗ |
| 2019-06-24 | DEVEER ROBERT K JR | Director | A-Award | A | Stock Option (right to buy) | 52,000 | 1.34 | 69.7K | 52,000 | — | ↗ |
| 2018-11-20 | Morris Arlene | Director | P-Purchase | A | Common Stock | 100 | 0.69 | 68.78 | 288,999 | — | ↗ |
| 2018-11-16 | WILLS STEPHEN T | Officer | P-Purchase | A | Common Stock | 5,000 | 0.76 | 3.8K | 3,903,239 | — | ↗ |
| 2018-11-16 | SPANA CARL | Director / Officer | P-Purchase | A | Common Stock | 20,000 | 0.79 | 15.8K | 4,348,102 | — | ↗ |
| 2018-11-16 | DUNTON ALAN W | Director | P-Purchase | A | Common Stock | 1,000 | 0.80 | 800.00 | 422,351 | — | ↗ |
| 2018-11-15 | DUNTON ALAN W | Director | P-Purchase | A | Common Stock | 332 | 0.80 | 265.60 | 412,351 | — | ↗ |
| 2018-06-26 | WILLS STEPHEN T | Officer | A-Award | A | Stock Option (right to buy) | 135,000 | 0.85 | 114.8K | 135,000 | — | ↗ |
| 2018-06-26 | SPANA CARL | Director / Officer | A-Award | A | Stock Option (right to buy) | 187,500 | 0.85 | 159.4K | 187,500 | — | ↗ |
| 2018-06-26 | Rossetti Angela | Director | A-Award | A | Common Stock | 28,000 | 0.00 | — | 343,333 | — | ↗ |
| 2018-06-26 | PRENDERGAST JOHN K A | Director | A-Award | A | Stock Option (right to buy) | 56,000 | 1.00 | 56.0K | 56,000 | — | ↗ |
| 2018-06-26 | Morris Arlene | Director | A-Award | A | Stock Option (right to buy) | 28,000 | 1.00 | 28.0K | 28,000 | — | ↗ |
| 2018-06-26 | Manning Anthony M. | Director | A-Award | A | Common Stock | 28,000 | 0.00 | — | 30,333 | — | ↗ |
| 2018-06-26 | Hull Joseph Stanley | Director | A-Award | A | Stock Option (right to buy) | 28,000 | 1.00 | 28.0K | 28,000 | — | ↗ |
| 2018-06-26 | DUNTON ALAN W | Director | A-Award | A | Common Stock | 28,000 | 0.00 | — | 408,353 | — | ↗ |
| 2018-06-26 | DEVEER ROBERT K JR | Director | A-Award | A | Stock Option (right to buy) | 28,000 | 1.00 | 28.0K | 28,000 | — | ↗ |
| 2017-12-12 | WILLS STEPHEN T | Officer | A-Award | A | Stock Option (right to acquire) | 575,000 | 0.85 | 488.8K | 575,000 | — | ↗ |
| 2017-12-12 | SPANA CARL | Director / Officer | A-Award | A | Common Stock | 625,000 | 0.00 | — | 3,411,102 | — | ↗ |
| 2017-12-12 | Rossetti Angela | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 0.85 | 25.5K | 30,000 | — | ↗ |
| 2017-12-12 | PRENDERGAST JOHN K A | Director | A-Award | A | Stock Option (right to buy) | 60,000 | 0.85 | 51.0K | 60,000 | — | ↗ |
| 2017-12-12 | Morris Arlene | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 0.85 | 25.5K | 30,000 | — | ↗ |
| 2017-12-12 | Manning Anthony M. | Director | A-Award | A | Common Stock | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2017-12-12 | Hull Joseph Stanley | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 0.85 | 25.5K | 30,000 | — | ↗ |
| 2017-12-12 | DUNTON ALAN W | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 0.85 | 25.5K | 30,000 | — | ↗ |
| 2017-12-12 | DEVEER ROBERT K JR | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 0.85 | 25.5K | 30,000 | — | ↗ |
| 2017-09-07 | Manning Anthony M. | Director | A-Award | A | Common Stock | 54,000 | 0.00 | — | 54,000 | — | ↗ |
| 2017-06-20 | WILLS STEPHEN T | Director | A-Award | A | Stock Option (right to acquire) | 859,000 | 0.37 | 317.8K | 859,000 | — | ↗ |
| 2017-06-20 | SPANA CARL | Director / Officer | A-Award | A | Stock Option (right to acquire) | 938,000 | 0.37 | 347.1K | 938,000 | — | ↗ |
| 2017-06-20 | Rossetti Angela | Director | A-Award | A | Stock Option (right to buy) | 54,000 | 0.37 | 20.0K | 54,000 | — | ↗ |
| 2017-06-20 | PRENDERGAST JOHN K A | Director | A-Award | A | Stock Option (right to buy) | 108,000 | 0.37 | 40.0K | 108,000 | — | ↗ |
| 2017-06-20 | Morris Arlene | Director | A-Award | A | Stock Option (right to buy) | 54,000 | 0.37 | 20.0K | 54,000 | — | ↗ |
| 2017-06-20 | Hull Joseph Stanley | Director | A-Award | A | Stock Option (right to buy) | 54,000 | 0.37 | 20.0K | 54,000 | — | ↗ |
| 2017-06-20 | DUNTON ALAN W | Director | A-Award | A | Stock Option (right to buy) | 54,000 | 0.37 | 20.0K | 54,000 | — | ↗ |
| 2017-06-20 | DEVEER ROBERT K JR | Director | A-Award | A | Stock Option (right to buy) | 54,000 | 0.37 | 20.0K | 54,000 | — | ↗ |
| 2017-06-12 | WILLS STEPHEN T | Officer | M-Exempt | A | Common Stock | 95,000 | 0.00 | — | 2,155,888 | — | ↗ |
| 2017-06-12 | SPANA CARL | Director / Officer | M-Exempt | A | Common Stock | 105,000 | 0.00 | — | 2,361,676 | — | ↗ |
| 2017-02-02 | WILLS STEPHEN T | Officer | A-Award | A | Common Stock | 300,000 | 0.00 | — | 1,939,041 | — | ↗ |
| 2017-02-02 | SPANA CARL | Director / Officer | A-Award | A | Common Stock | 325,000 | 0.00 | — | 2,114,829 | — | ↗ |
| 2016-09-07 | WILLS STEPHEN T | Officer | A-Award | A | Common Stock | 268,000 | 0.00 | — | 1,842,041 | — | ↗ |
| 2016-09-07 | SPANA CARL | Director / Officer | A-Award | A | Common Stock | 290,000 | 0.00 | — | 2,011,079 | — | ↗ |
| 2016-06-27 | WILLS STEPHEN T | Officer | M-Exempt | A | Common Stock | 75,000 | 0.00 | — | 1,601,203 | — | ↗ |
| 2016-06-27 | SPANA CARL | Director / Officer | M-Exempt | A | Common Stock | 87,500 | 0.00 | — | 1,758,020 | — | ↗ |
| 2016-06-13 | WILLS STEPHEN T | Officer | F-InKind | D | Common Stock | 28,899 | 0.49 | 14.2K | 1,392,453 | — | ↗ |
| 2016-06-13 | SPANA CARL | Director / Officer | F-InKind | D | Common Stock | 38,819 | 0.49 | 19.0K | 1,520,520 | — | ↗ |
| 2016-06-13 | Rossetti Angela | Director | M-Exempt | A | Common Stock | 20,000 | 0.00 | — | 140,625 | — | ↗ |
| 2016-06-13 | PRENDERGAST JOHN K A | Director | M-Exempt | A | Common Stock | 40,000 | 0.00 | — | 466,767 | — | ↗ |
| 2016-06-13 | Morris Arlene | Director | M-Exempt | A | Common Stock | 20,000 | 0.00 | — | 80,625 | — | ↗ |
| 2016-06-13 | Hull Joseph Stanley | Director | M-Exempt | A | Common Stock | 20,000 | 0.00 | — | 265,625 | — | ↗ |
| 2016-06-13 | DUNTON ALAN W | Director | M-Exempt | A | Common Stock | 20,000 | 0.00 | — | 195,645 | — | ↗ |
| 2016-06-13 | DEVEER ROBERT K JR | Director | M-Exempt | A | Common Stock | 20,000 | 0.00 | — | 294,685 | — | ↗ |
| 2016-06-09 | Rossetti Angela | Director | A-Award | A | Common Stock | 37,500 | 0.00 | — | 120,625 | — | ↗ |
| 2016-06-09 | PRENDERGAST JOHN K A | Director | A-Award | A | Common Stock | 75,000 | 0.00 | — | 426,767 | — | ↗ |
| 2016-06-09 | Morris Arlene | Director | A-Award | A | Common Stock | 37,500 | 0.00 | — | 60,625 | — | ↗ |
| 2016-06-09 | Hull Joseph Stanley | Director | A-Award | A | Stock Option (right to buy) | 37,500 | 0.50 | 18.8K | 221,000 | — | ↗ |
| 2016-06-09 | DUNTON ALAN W | Director | A-Award | A | Common Stock | 37,500 | 0.00 | — | 175,645 | — | ↗ |
| 2016-06-09 | DEVEER ROBERT K JR | Director | A-Award | A | Stock Option (right to buy) | 37,500 | 0.50 | 18.8K | 224,500 | — | ↗ |
| 2015-12-08 | WILLS STEPHEN T | Officer | A-Award | A | Common Stock | 300,000 | 0.00 | — | 1,483,852 | — | ↗ |
| 2015-12-08 | SPANA CARL | Director / Officer | A-Award | A | Common Stock | 325,000 | 0.00 | — | 1,623,089 | — | ↗ |
| 2015-12-08 | Rossetti Angela | Director | A-Award | A | Common Stock | 30,000 | 0.00 | — | 101,666 | — | ↗ |
| 2015-12-08 | PRENDERGAST JOHN K A | Director | A-Award | A | Common Stock | 100,000 | 0.00 | — | 428,849 | — | ↗ |
| 2015-12-08 | Morris Arlene | Director | A-Award | A | Common Stock | 20,000 | 0.00 | — | 31,666 | — | ↗ |
| 2015-12-08 | Hull Joseph Stanley | Director | A-Award | A | Common Stock | 50,000 | 0.00 | — | 246,666 | — | ↗ |
| 2015-12-08 | HOROVITZ ZOLA P | Director | A-Award | A | Common Stock | 50,000 | 0.00 | — | 250,666 | — | ↗ |
| 2015-12-08 | DUNTON ALAN W | Director | A-Award | A | Common Stock | 40,000 | 0.00 | — | 166,686 | — | ↗ |
| 2015-12-08 | DEVEER ROBERT K JR | Director | A-Award | A | Common Stock | 50,000 | 0.00 | — | 275,726 | — | ↗ |
| 2015-12-04 | Hull Joseph Stanley | Director | P-Purchase | A | Common Stock | 2,500 | 0.66 | 1.7K | 21,500 | — | ↗ |
| 2015-11-19 | Hull Joseph Stanley | Director | P-Purchase | A | Common Stock | 2,000 | 0.65 | 1.3K | 19,000 | — | ↗ |
| 2015-10-02 | DEVEER ROBERT K JR | Director | P-Purchase | A | Common Stock | 10,000 | 0.82 | 8.2K | 222,393 | — | ↗ |
| 2015-06-27 | WILLS STEPHEN T | Officer | M-Exempt | A | Common Stock | 100,000 | 0.00 | — | 1,226,572 | — | ↗ |
| 2015-06-27 | SPANA CARL | Director / Officer | M-Exempt | A | Common Stock | 110,000 | 0.00 | — | 1,354,864 | — | ↗ |
| 2015-06-25 | WILLS STEPHEN T | Officer | M-Exempt | A | Common Stock | 75,000 | 0.00 | — | 1,249,387 | — | ↗ |
| 2015-06-25 | SPANA CARL | Director / Officer | M-Exempt | A | Common Stock | 87,500 | 0.00 | — | 1,387,213 | — | ↗ |
| 2015-06-25 | Rossetti Angela | Director | M-Exempt | A | Common Stock | 15,000 | 0.00 | — | 61,666 | — | ↗ |
| 2015-06-25 | PRENDERGAST JOHN K A | Director | M-Exempt | A | Common Stock | 30,000 | 0.00 | — | 313,450 | — | ↗ |
| 2015-06-25 | Hull Joseph Stanley | Director | M-Exempt | A | Common Stock | 15,000 | 0.00 | — | 185,832 | — | ↗ |
| 2015-06-25 | HOROVITZ ZOLA P | Director | M-Exempt | A | Common Stock | 15,000 | 0.00 | — | 192,666 | — | ↗ |
| 2015-06-25 | DUNTON ALAN W | Director | M-Exempt | A | Common Stock | 15,000 | 0.00 | — | 116,686 | — | ↗ |
| 2015-06-25 | DEVEER ROBERT K JR | Director | M-Exempt | A | Common Stock | 15,000 | 0.00 | — | 207,726 | — | ↗ |
| 2015-06-11 | WILLS STEPHEN T | Officer | A-Award | A | restricted share units | 190,000 | 0.00 | — | 190,000 | — | ↗ |
| 2015-06-11 | SPANA CARL | Director / Officer | A-Award | A | restricted share units | 210,000 | 0.00 | — | 210,000 | — | ↗ |
| 2015-06-11 | Rossetti Angela | Director | A-Award | A | stock option (right to buy) | 20,000 | 1.08 | 21.6K | 20,000 | — | ↗ |
| 2015-06-11 | PRENDERGAST JOHN K A | Director | A-Award | A | stock option (right to buy) | 40,000 | 1.08 | 43.2K | 40,000 | — | ↗ |
| 2015-06-11 | Morris Arlene | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2015-06-11 | Hull Joseph Stanley | Director | A-Award | A | restricted share units | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2015-06-11 | HOROVITZ ZOLA P | Director | A-Award | A | restricted share units | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2015-06-11 | DUNTON ALAN W | Director | A-Award | A | stock option (right to buy) | 20,000 | 1.08 | 21.6K | 20,000 | — | ↗ |
| 2015-06-11 | DEVEER ROBERT K JR | Director | A-Award | A | stock option (right to buy) | 20,000 | 1.08 | 21.6K | 20,000 | — | ↗ |
| 2014-07-18 | WILLS STEPHEN T | Officer | F-InKind | D | Common Stock | 16,731 | 1.02 | 17.1K | 418,337 | — | ↗ |
| 2014-07-18 | SPANA CARL | Director / Officer | M-Exempt | A | Common Stock | 56,250 | 0.00 | — | 451,116 | — | ↗ |
| 2014-07-02 | WILLS STEPHEN T | Officer | M-Exempt | A | Common Stock | 100,000 | 0.00 | — | 410,488 | — | ↗ |
| 2014-07-02 | SPANA CARL | Director / Officer | M-Exempt | A | Common Stock | 110,000 | 0.00 | — | 435,841 | — | ↗ |
| 2014-06-25 | WILLS STEPHEN T | Officer | A-Award | A | restricted share units | 150,000 | 0.00 | — | 150,000 | — | ↗ |
Executive team
Top executives
Shares Outstanding
26.01M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Carl Spana, Ph.D., Chief Executive Officer and President | 700.0K | — | 195.4K | 178.7K | 357.0K | 17.3K | 1.45M | 25.83% | ↗ |
| 2 | 2024 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer and Executive Vice President | 650.0K | — | 170.7K | 155.8K | 431.5K | 16.6K | 1.42M | 22.92% | ↗ |
| 3 | 2023 | Carl Spana, Ph.D., Chief Executive Officer and President | 700.0K | — | 170.5K | 154.3K | 262.5K | 16.5K | 1.30M | 24.91% | ↗ |
| 4 | 2023 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer and Executive Vice President | 650.0K | — | 148.5K | 134.1K | 243.8K | 16.8K | 1.19M | 23.69% | ↗ |
| 5 | 2022 | Carl Spana, Ph.D., Chief Executive Officer and President | 640.0K | — | 149.9K | 269.1K | 288.0K | 15.3K | 1.36M | 30.76% | ↗ |
| 6 | 2022 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer and Executive Vice President | 590.0K | — | 131.4K | 233.1K | 265.5K | 15.1K | 1.23M | 29.51% | ↗ |
| 7 | 2021 | Carl Spana, Ph.D., Chief Executive Officer and President | 620.0K | — | 542.5K | 193.8K | 290.0K | 14.5K | 1.66M | 44.33% | ↗ |
| 8 | 2021 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer and Executive Vice President | 570.0K | — | 466.1K | 167.5K | 267.0K | 14.9K | 1.49M | 42.65% | ↗ |
| 9 | 2020 | Carl Spana, Ph.D., Chief Executive Officer and President | 600.0K | — | 712.4K | 712.6K | 252.0K | 15.6K | 2.29M | 62.16% | ↗ |
| 10 | 2020 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer and Executive Vice President | 550.0K | — | 613.8K | 613.8K | 231.0K | 16.2K | 2.02M | 60.63% | ↗ |
| 11 | 2019 | Carl Spana, Ph.D., Chief Executive Officer and President | 505.4K | — | 616.7K | 632.2K | 506.0K | 14.1K | 2.27M | 54.91% | ↗ |
| 12 | 2019 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer and Executive Vice President | 461.7K | — | 527.8K | 542.2K | 462.0K | 14.1K | 2.01M | 53.29% | ↗ |
| 13 | 2018 | Carl Spana, Ph.D., Chief Executive Officer and President | 490.7K | — | 1.42M | 1.03M | 263.0K | 13.9K | 3.22M | 76.13% | ↗ |
| 14 | 2018 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer and Executive Vice President | 448.3K | — | 1.19M | 869.4K | 240.0K | 13.8K | 2.76M | 74.57% | ↗ |
| 15 | 2017 | Carl Spana, Ph.D., Chief Executive Officer and President | 476.4K | — | 368.1K | 367.4K | 458.0K | 13.3K | 1.68M | 43.70% | ↗ |
| 16 | 2017 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer, Executive Vice President, Secretary and Treasurer | 435.2K | — | 338.3K | 336.6K | 438.0K | 13.3K | 1.56M | 43.23% | ↗ |
| 17 | 2017 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer and Executive Vice President | 435.2K | — | 338.3K | 336.6K | 438.0K | 13.3K | 1.56M | 43.23% | ↗ |
| 18 | 2016 | Carl Spana, Ph.D., Chief Executive Officer and President | 476.4K | — | 354.3K | — | 101.0K | 13.6K | 945.2K | 37.48% | ↗ |
| 19 | 2016 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer, Executive Vice President, Secretary and Treasurer | 435.2K | — | 327.0K | — | 92.0K | 13.6K | 867.8K | 37.68% | ↗ |
| 20 | 2016 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer and Executive Vice President | 435.2K | 92.0K | 327.0K | — | — | 13.6K | 867.8K | 37.68% | ↗ |
| 21 | 2015 | Carl Spana, Ph.D., Chief Executive Officer and President | 462.5K | 195.0K | 226.8K | 234.8K | — | 18.9K | 1.14M | 40.56% | ↗ |
| 22 | 2015 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer and Executive Vice President | 422.5K | 203.0K | 205.2K | 211.9K | — | 18.4K | 1.06M | 39.31% | ↗ |
| 23 | 2014 | Carl Spana, Ph.D., chief executive officer and president | 450.0K | — | 178.5K | 143.1K | 170.0K | 22.5K | 964.1K | 33.36% | ↗ |
| 24 | 2014 | Carl Spana, Ph.D., Chief Executive Officer and President | 450.0K | — | 178.5K | 143.1K | 170.0K | 22.5K | 964.1K | 33.36% | ↗ |
| 25 | 2014 | Stephen T. Wills, MST, CPA, chief financial officer, chief operating officer and executive vice president | 410.0K | — | 153.0K | 122.6K | 140.0K | 17.4K | 843.0K | 32.70% | ↗ |
| 26 | 2014 | Stephen T. Wills, MST, CPA, Chief Financial Officer, Chief Operating Officer and Executive Vice President | 410.0K | — | 153.0K | 122.6K | 140.0K | 17.4K | 843.0K | 32.70% | ↗ |
| 27 | 2013 | Carl Spana, Ph.D., chief executive officer and president | 436.8K | — | 217.4K | 246.0K | 250.0K | 12.9K | 1.16M | 39.84% | ↗ |
| 28 | 2013 | Carl Spana, Ph.D., chief executive officer and president | 436.8K | — | 217.4K | 246.0K | 250.0K | 12.9K | 1.16M | 39.84% | ↗ |
| 29 | 2013 | Stephen T. Wills, MST, CPA, chief financial officer, chief operating officer and executive vice president | 394.2K | — | 203.2K | 222.7K | 225.0K | 13.0K | 1.06M | 40.26% | ↗ |
| 30 | 2013 | Stephen T. Wills, MST, CPA, chief financial officer, chief operating officer and executive vice president | 394.2K | — | 203.2K | 222.7K | 225.0K | 13.0K | 1.06M | 40.26% | ↗ |
| 31 | 2012 | Carl Spana, Ph.D., chief executive officer and president | 420.0K | — | — | — | 112.5K | 12.8K | 545.3K | 0.00% | ↗ |
| 32 | 2012 | Stephen T. Wills, MST, CPA, chief financial officer, chief operating officer and executive vice president | 375.0K | — | — | — | 105.0K | 13.4K | 493.4K | 0.00% | ↗ |
| 33 | 2011 | Carl Spana, Ph.D., chief executive officer and president | 400.0K | — | 257.5K | 228.3K | 120.0K | 12.5K | 1.02M | 47.71% | ↗ |
| 34 | 2011 | Stephen T. Wills, MST, CPA, chief financial officer, chief operating officer and executive vice president | 330.0K | — | 227.6K | 190.3K | 100.0K | 12.5K | 860.2K | 48.58% | ↗ |
| 35 | 2011 | Trevor Hallam, Ph.D., former executive vice president of research and development | 165.0K | — | 34.0K | — | — | 169.2K | 368.2K | 9.23% | ↗ |
| 36 | 2010 | Carl Spana, Ph.D., chief executive officer and president | 390.0K | — | — | 62.3K | — | 12.3K | 464.6K | 13.41% | ↗ |
| 37 | 2010 | Stephen T. Wills, MST, CPA, chief financial officer, chief operating officer and executive vice president | 321.0K | — | — | 49.8K | — | 12.3K | 383.1K | 13.01% | ↗ |
| 38 | 2010 | Trevor Hallam, Ph.D., executive vice president of research and development | 321.0K | — | — | 49.8K | — | 12.3K | 383.1K | 13.01% | ↗ |
| 39 | 2010 | Stephen T. Wills, MST, CPA, chief financial officer and executive vice president of operations | 321.0K | — | — | 49.8K | — | 12.3K | 383.1K | 13.01% | ↗ |
| 40 | 2010 | Trevor Hallam, Ph.D., former executive vice president of research and development | 321.0K | — | — | 49.8K | — | 12.3K | 383.1K | 13.01% | ↗ |
| 41 | 2009 | Carl Spana, Ph.D., chief executive officer and president | 390.0K | 25.0K | 22.5K | 38.5K | — | 9.8K | 485.7K | 12.55% | ↗ |
| 42 | 2009 | Trevor Hallam, Ph.D., executive vice president of research and development | 321.0K | 25.0K | 22.5K | 30.8K | — | 11.5K | 410.8K | 12.97% | ↗ |
| 43 | 2009 | Stephen T. Wills, MST, CPA, chief financial officer and executive vice president of operations | 321.0K | 25.0K | 22.5K | 30.8K | — | 11.5K | 410.8K | 12.97% | ↗ |
| 44 | 2008 | Carl Spana, Ph.D., chief executive officer and president | 390.0K | — | 281.8K | 66.0K | — | 5.7K | 743.5K | 46.78% | ↗ |
| 45 | 2008 | Carl Spana, Ph.D., officer and president | 390.0K | — | 281.8K | 66.0K | — | 5.7K | 743.5K | 46.78% | ↗ |
| 46 | 2008 | Stephen T. Wills, financial officer and | 321.0K | — | 217.0K | 52.8K | — | 14.7K | 605.5K | 44.56% | ↗ |
| 47 | 2008 | Trevor Hallam, Ph.D., executive vice president of research and development | 321.0K | — | 217.0K | 52.8K | — | 14.7K | 605.5K | 44.56% | ↗ |
| 48 | 2008 | Trevor Hallam, Ph.D., president of research | 321.0K | — | 217.0K | 52.8K | — | 14.7K | 605.5K | 44.56% | ↗ |
| 49 | 2008 | Stephen T. Wills, MST, CPA, chief financial officer and executive vice president of operations | 321.0K | — | 217.0K | 52.8K | — | 14.7K | 605.5K | 44.56% | ↗ |
| 50 | 2007 | Carl Spana, Ph.D., officer and president | 370.0K | 60.0K | 193.6K | 48.8K | — | 3.2K | 675.7K | 35.88% | ↗ |
| 51 | 2007 | Trevor Hallam, Ph.D., president of research | 305.0K | 42.5K | 154.9K | 33.5K | — | 7.1K | 542.9K | 34.69% | ↗ |
| 52 | 2007 | Stephen T. Wills, CPA, executive vice president of operations and chief financial officer | 305.0K | 42.5K | 154.9K | 33.5K | — | 6.9K | 542.7K | 34.70% | ↗ |
| 53 | 2007 | Stephen T. Wills, financial officer and | 305.0K | 42.5K | 154.9K | 33.5K | — | 6.9K | 542.7K | 34.70% | ↗ |
| 54 | 2007 | Shubh D. Sharma, Ph.D., vice president and chief scientific officer | 201.9K | 40.4K | — | — | — | 6.1K | 248.4K | 0.00% | ↗ |
| 55 | 2006 | Carl Spana, Ph.D., president and chief executive officer | 350.0K | 100.0K | — | — | — | 3.3K | 453.3K | 0.00% | ↗ |
| 56 | 2006 | Stephen T. Wills, CPA, executive vice president of operations and chief financial officer | 285.0K | 75.0K | — | — | — | 6.7K | 366.7K | 0.00% | ↗ |
| 57 | 2006 | Trevor Hallam, Ph.D., executive vice president of | 275.0K | 75.0K | — | — | — | 7.5K | 357.5K | 0.00% | ↗ |
| 58 | 2006 | Shubh D. Sharma, Ph.D., vice president and chief scientific officer | 201.9K | — | — | — | — | 6.6K | 208.5K | 0.00% | ↗ |
| 59 | 2005 | Carl Spana, Ph.D., chief executive officer | 340.0K | 260.0K | — | — | — | 3.2K | 603.2K | 0.00% | ↗ |
| 60 | 2005 | Carl Spana, Ph.D., president and chief executive officer | 340.0K | 260.0K | — | — | — | 3.2K | 603.2K | 0.00% | ↗ |
| 61 | 2005 | Stephen T. Wills, CPA, executive vice president of operations and chief financial officer | 275.0K | 240.0K | — | — | — | 6.6K | 521.6K | 0.00% | ↗ |
| 62 | 2005 | Shubh D. Sharma, Ph.D., vice president and chief scientific officer | 196.0K | 95.0K | — | — | — | 6.5K | 297.5K | 0.00% | ↗ |
| 63 | 2005 | Shubh D. Sharma, Ph.D., vice president and chief technical officer | 196.0K | 95.0K | — | — | — | 6.5K | 297.5K | 0.00% | ↗ |
| 64 | 2005 | Trevor Hallam, Ph.D., president of research | 39.7K | 25.0K | — | — | — | 20.00 | 64.7K | 0.00% | ↗ |
| 65 | 2005 | Trevor Hallam, Ph.D., executive vice president of | 39.7K | 25.0K | — | — | — | 20.00 | 64.7K | 0.00% | ↗ |
| 66 | 2004 | Carl Spana, Ph.D., chief executive officer | 320.0K | 50.0K | — | — | — | 3.8K | 373.8K | 0.00% | ↗ |
| 67 | 2004 | Carl Spana, Ph.D., president and chief executive officer | 320.0K | 50.0K | — | — | — | 3.8K | 373.8K | 0.00% | ↗ |
| 68 | 2004 | Stephen T. Wills, CPA, executive vice president of operations and chief financial officer | 265.0K | 40.0K | — | — | — | 19.1K | 324.1K | 0.00% | ↗ |
| 69 | 2004 | Shubh D. Sharma, Ph.D., vice president and chief scientific officer | 185.0K | 23.3K | — | — | — | 19.1K | 227.4K | 0.00% | ↗ |
| 70 | 2004 | Shubh D. Sharma, Ph.D., vice president and chief technical officer | 185.0K | 23.3K | — | — | — | 19.1K | 227.4K | 0.00% | ↗ |
| 71 | 2003 | Stephen T. Wills, CPA, executive vice president of operations and chief financial officer | 225.0K | 40.0K | — | — | — | 18.1K | 283.1K | 0.00% | ↗ |
| 72 | 2003 | Shubh D. Sharma, Ph.D., vice president and chief technical officer | 165.0K | 23.3K | — | — | — | 17.1K | 205.4K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Stephen T. Wills | Chief Financial Officer, Chief Operating Officer, Executive Vice President, Treasurer & Secretary | 1M | male |
| Carl Spana | Co-Founder, President, Chief Executive Officer & Director | 1M | — |
| John Dodd | Senior Vice President of Preclinical Development | — | male |
| Burns McClellan | Vice President of Investor Relations | — | — |
| Robert Jordan | Senior Vice President of Program Operations | — | male |
| Stephen A. Slusher | Chief Legal Officer | — | male |
| Michael Raizman | Chief Medical Officer | — | — |
| James E. Hattersley | Senior Vice President of Business Development | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PTN
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
